But is not it also true to say that while lawsuits may have removed some companies from the markets, that lack of profitability was an even bigger driving factor, that many of these vaccine companies would have millions of doses left over at the end of the year that they would lose money on, they faced enormous regulatory hurdles which were very expensive.